Half of prostate cancers could potentially benefit from new type of cancer drugs, study finds
Wednesday, May 18, 2011 - 09:30
in Health & Medicine
About half of prostate cancers have a genetic anomaly that appears to make tumor cells responsive to a new class of cancer-fighting drugs, a new study from the University of Michigan Comprehensive Cancer Center finds.